申请人:CIPLA LIMITED
公开号:US20160002166A1
公开(公告)日:2016-01-07
The present invention relates to a process for the preparation of Compound (A):
wherein the process comprises contacting atazanavir base (Compound (II))
with sulphuric acid in a combination of two or more solvents and isolating compound (A). The present invention also relates to substantially pure Compound (A), and to Compound (A) devoid of mesityl oxide impurity. Mesityl oxide has the following formula:
本发明涉及一种制备化合物(A)的过程:其中该过程包括将阿扎那韦碱(化合物(II))与硫酸在两种或多种溶剂的组合中接触,并分离化合物(A)。本发明还涉及基本纯净的化合物(A)以及不含二甲基苯酮杂质的化合物(A)。二甲基苯酮的化学式为: